K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · EXAS
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | EXAS | EXACT SCIENCES | EXACT SCIENCES | $400K | HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act H.R. 7118 support Genomic Answers for Childrens Health Act Support colorectal cancer screening prevention standards Support patient access to cancer screening and diagnostics Support veteran access to guideline-recommended colorectal cancer screening |
| 2026-04-20 | EXAS | EXACT SCIENCES | THE DUBERSTEIN GROUP INC. | $75K | Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related to cancer screenings Expanding access to cancer screening |
| 2026-04-19 | EXAS | EXACT SCIENCES CORPORATION | ALPINE GROUP PARTNERS, LLC. | $60K | H.R. 842, S.339 The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.7118 Genomic Answers for Children's Health Act H.R. 842, S.339 the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.7118 Genomic Answers for Children's Health Act FY27 MilCon-VA appropriations Access to colorectal cancer screening tests |
| 2026-01-22 | EXAS | EXACT SCIENCES | EXACT SCIENCES | $420K | HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. Support colorectal cancer screening standards Support patient access to cancer screening and diagnostics. Support HR 1780/S 642 Finn Sawyer Access to Cancer Testing Act Support S 1410 Find It Early Act Support HR 2921/S 2745 Federal Firefighter Cancer Detection and Prevention Act of 2025 Support HR 1610 FIRE Cancer Act Support HR 4752/S 2760 Reducing Hereditary Cancer Act Support HR 7714 Colorectal Cancer Early Detection Act Support S 1717 Ensuring Patient Access to Critical Breakthrough Products Act Support veteran access to guideline-recommended colorectal cancer screening. |
| 2026-01-20 | EXAS | EXACT SCIENCES | THE DUBERSTEIN GROUP INC. | $75K | Medicare Multi-Cancer Early Detection Screening Coverage Act |
| 2026-01-20 | EXAS | EXACT SCIENCES CORPORATION | ALPINE GROUP PARTNERS, LLC. | $60K | H.R. 842, S.339 The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related FDA regulation of laboratory tests H.R. 842, S.339 the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act FY26 MilCon-VA appropriations Access to colorectal cancer screening tests |
| 2025-10-23 | EXAS | EXACT SCIENCES | EXACT SCIENCES | $450K | Support veteran access to guideline-recommended colorectal cancer screening. HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act: This bill allows, beginning in 2028, for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. Coverage is limited to those under a certain age (age 68 in 2028, increased by one year every year thereafter) and to one test every 11 months. Support patient access to cancer screening and diagnostics. Support HR 1780/S 642 Finn Sawyer Access to Cancer Testing Act Support S 1410 Find It Early Act Support HR 2921/S 2745 Federal Firefighter Cancer Detection and Prevention Act of 2025 Support HR 1610 FIRE Cancer Act Support HR 4752/S 2760 Reducing Hereditary Cancer Act Support HR 771 |
| 2025-10-20 | EXAS | EXACT SCIENCES | THE DUBERSTEIN GROUP INC. | $75K | Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S.339: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Expanding access to cancer screening |
| 2025-10-19 | EXAS | EXACT SCIENCES CORPORATION | ALPINE GROUP PARTNERS, LLC. | $60K | H.R. 842, S.339 The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related FDA regulation of laboratory tests H.R. 842, S.339 the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act FY26 MilCon-VA appropriations Access to colorectal cancer screening tests |
| 2025-07-25 | EXAS | EXACT SCIENCES | EXACT SCIENCES | $480K | Support legislative efforts to develop alternative diagnostics legislation in lieu of LDT rule. Support veteran access to guideline-recommended colorectal cancer screening. HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act: This bill allows, beginning in 2028, for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. Coverage is limited to those under a certain age (age 68 in 2028, increased by one year every year thereafter) and to one test every 11 months. |
| 2025-07-21 | EXAS | EXACT SCIENCES | THE DUBERSTEIN GROUP INC. | $75K | Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S.339: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Expanding access to cancer screening |
| 2025-07-21 | EXAS | EXACT SCIENCES CORPORATION | ALPINE GROUP PARTNERS, LLC. | $60K | H.R. 842, S.339 The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related FDA regulation of laboratory tests H.R. 842, S.339 the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act FY26 MilCon-VA appropriations Access to colorectal cancer screening tests |
| 2025-05-02 | EXAS | EXACT SCIENCES | EXACT SCIENCES | $470K | HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act: This bill allows, beginning in 2028, for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. Coverage is limited to those under a certain age (age 68 in 2028, increased by one year every year thereafter) and to one test every 11 months. Support legislative efforts to develop alternative diagnostics legislation in lieu of LDT rule. Support veteran access to guideline-recommended colorectal cancer screening. |
| 2025-04-21 | EXAS | EXACT SCIENCES | THE DUBERSTEIN GROUP INC. | $75K | Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S.339: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Expanding access to cancer screening |
| 2025-04-17 | EXAS | EXACT SCIENCES CORPORATION | ALPINE GROUP PARTNERS, LLC. | $60K | H.R. 842, S.339 The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related FDA regulation of laboratory tests H.R. 842, S.339 the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.1620, S.755 Finn Sawyer Access to Cancer Testing Act FY25 MilCon appropriations Access to colorectal cancer screening tests |
| 2025-01-21 | EXAS | EXACT SCIENCES | EXACT SCIENCES | $470K | Support Medicare Multi-Cancer Early Detection Screening Coverage Act (HR 2407/ S 2085) Support Reducing Hereditary Cancer Act (HR 1526/S 765) Support Finn Sawyer Access to Cancer Testing Act (HR 1780/S 642) Support Equitable Community Access to Pharmacist Services Act (HR 1770) Support Find It Early Act (HR 3086) Support Access to Genetic Counselor Services Act HR 3876/S. 2323 Support Federal Firefighter Cancer Detection and Prevention Act of 2023 (HR 2852) Support Barbosa Act (S 302) Support with modifications Verifying Accurate Leading-edge IVCT Development Act of 2023 (HR 4128) Support Find It Early Act (HR 3086) Support military colorectal cancer screening parity |
| 2025-01-21 | EXAS | EXACT SCIENCES | THE DUBERSTEIN GROUP INC. | $75K | Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.2407 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Outreach re: expanding access to cancer detection technologies Expanding access to cancer screening |
| 2025-01-19 | EXAS | EXACT SCIENCES CORPORATION | ALPINE GROUP PARTNERS, LLC. | $60K | H.R. 2407, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 2085, the Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related FDA regulation of laboratory tests H.R. 2407, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 2085, the Medicare Multi-Cancer Early Detection Screening Coverage Act Finn Sawyer Access to Cancer Testing Act (H.R. 1780 / S. 642) Access to Genetic Counselor Services Act (H.R. 3876 / S. 2323) FY25 MilCon appropriations Access to colorectal cancer screening tests |